nabumetone


Also found in: Dictionary, Thesaurus, Wikipedia.

nabumetone

 [nah-bu´mĕ-tōn]
a nonsteroidal antiinflammatory drug used in treatment of rheumatoid arthritis and osteoarthritis.

nabumetone

/na·bu·me·tone/ (nah-bu´mĕ-tōn) a nonsteroidal antiinflammatory drug used in the treatment of osteoarthritis and rheumatoid arthritis.

nabumetone

(nə-byo͞o′mə-tōn′)
n.
An anti-inflammatory and analgesic drug of the NSAID class, C15H16O2, used primarily to treat osteoarthritis and rheumatoid arthritis.

nabumetone

A NON-STEROIDAL ANTI-INFLAMMATORY DRUG used to treat arthritis and other painful conditions. A brand name is Relifex.

nabumetone (nəbū´mətōn´),

n brand name: Relafen;
drug class: nonsteroidal antiinflammatory;
action: inhibits prostaglandin synthesis by interfering with cyclooxygenase needed for biosynthesis; possesses analgesic, antiinflammatory, and antipyretic properties;
uses: osteoarthritis, rheumatoid arthritis.

Patient discussion about nabumetone

Q. can u take nabumetone and dicfofenac at the same time

A. thanks 4 the info my dr. nurse said to take both,but pharmacy said not to didn't know what to do .

More discussions about nabumetone
References in periodicals archive ?
The risk of gastrointestinal hemorrhage or perforation with nabumetone in relation to these other two NSAIDs remains unknown.
Nabumetone, 4-6-methoxy-2-naphthyl)-butan-2-one, is a naphthalene derivative that, after first pass through the liver, is metabolized to 3-acetic-6-methoxynaphthalene and further metabolized to 3-acetic-6-hydroxynaphthalene before being excreted in the urine [5].
Nabumetone is indicated for the relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.
0 million payment to settle all patent litigation involving Nabumetone in 2004 offset by an increase of $0.
This proposed Settlement of a class action lawsuit is over the pricing of the brand name drug Relafen(R) and its generic equivalent, nabumetone.
generic form of Glucophage(R)), and the anti-inflammatory nabumetone (a
5 million related to patent infringement litigation involving Nabumetone which increased earnings by $0.
anti-inflammatory nabumetone (a generic form of Relifex(R)/Relafen(R)).
13 per share related to a $10 million payment received to settle all litigation related to Nabumetone, compared to $0.
Three distributors of generic pharmaceutical products have filed ANDAs for nabumetone, the active ingredient in Relafen, accompanied in each case with a certification of patent invalidity.
First quarter and full year guidance includes a payment of $10 million from GlaxoSmithKline to settle all litigation relating to Nabumetone.
Miconazole Nitrate powder, Midazolam injection, Nabumetone tab.